FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

974511000001103: Theophylline 250mg modified-release tablets 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22529101000001118 Theophylline 250mg modified-release tablets 60 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22529201000001113 Theophylline 250mg modified-release tablets 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Theophylline 250mg modified-release tablets 60 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Is pack of Theophylline 250mg m/r tablet false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has active ingredient Theophylline false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has VMP Theophylline 250mg m/r tablet false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has specific active ingredient Theophylline true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has VMP Theophylline 250mg modified-release tablets false Inferred relationship Existential restriction modifier
Theophylline 250mg modified-release tablets 60 tablet Has VMP Theophylline 250mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nuelin SA 250 tablets (Viatris UK Healthcare Ltd) 60 tablet Is a True Theophylline 250mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier
Nuelin SA 250 tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Is a True Theophylline 250mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start